Instalimb
Instalimb manufactures prosthetic and orthotic devices using digital fabrication technology, utilizing 3D scanning, computer-aided design, and additive manufacturing to produce custom mobility aids. The process involves capturing anatomical data remotely to create sockets and structural components, which are distributed to individuals requiring physical support and mobility assistance. The production workflow…
Funding snapshot
About
Instalimb manufactures prosthetic and orthotic devices using digital fabrication technology, utilizing 3D scanning, computer-aided design, and additive manufacturing to produce custom mobility aids. The process involves capturing anatomical data remotely to create sockets and structural components, which are distributed to individuals requiring physical support and mobility assistance. The production workflow integrates machine learning to optimize design and assembly processes. Founded in 2017 and headquartered in Chiyoda City, Japan, Instalimb has raised approximately $10.6M in Series B funding from investors including Nippon Express, JIC Venture Growth Investments, Dai-Ichi Life, Mitsubishi UFJ Capital, Mizuho Capital, Global Brain, Kyocera, and UTokyo Innovation Platform. The company addresses the accessibility gap in prosthetic care by enabling remote measurement and digital fabrication of custom prosthetic devices, reducing the time and cost of fitting while expanding access to quality mobility aids in underserved regions.
Business model
Orthopedics > Medical Devices > Therapies > Rehabilitation > Prosthetics > Prosthetic Leg
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.